Is Delcath Systems Inc (DCTH) overvalued? · P/E 1067, rev $37.2M
Delcath Systems Inc (DCTH) is a medical devices company listed on US.
This page asks whether Delcath Systems Inc (DCTH) looks expensive on cached numbers — not a short thesis.
Latest reported DCTH revenue for 2024-12-31 was $37.2M. Net income was -$26.4M. Revenue was up 1701.7% from 2023-12-31 to 2024-12-31. DCTH currently screens at market cap $368.3M and trailing P/E 1067.0.
DCTH currently screens at market cap $368.3M and trailing P/E 1067.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DCTH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DCTH stock page for the full model, not this heading.
Not investment advice.